Compare HCA Health Inc (HCA) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Symbotic Inc — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Symbotic Inc trades at $42.63 (market cap $5.46B). The key difference: HCA Health Inc is far larger — about 17.6× Symbotic Inc's market cap, and HCA Health Inc pays a 0.7% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Symbotic Inc for 23 Days on average.
| HCA | SYM | |
|---|---|---|
Market Cap | $96.35B | $5.46B |
Volume | 1,079,453 | 1,965,805 |
Sector | Health | Industrials |
52-Week High | $545.13 | $87.30 |
52-Week Low | $361.32 | $38.22 |
Typical Hold Time | 76 Days | 23 Days |
Enterprise Value | $146.88B | $3.72B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $451.09, up 2.71% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q4 2025 and Q1-Q2 2026 exceeding expectations, supported by robust revenue growth from $70.6B in 2024 to $75.6B in 2025. Valuation metrics remain attractive with P/E of 14.92 and P/S of 1.31, while technical indicators signal bullish momentum above key support levels.
The outlook remains positive with 63% analyst buy ratings and $461.12 consensus target, though legal investigations and high debt levels pose risks. Revenue growth and operational efficiency provide upside potential, but investors should monitor regulatory developments and debt management closely given the 80.9% debt-to-asset ratio in 2025.
SYM trades at $42.63, down 1.57% today, with bearish technical signals dominating (15 sell vs 2 buy indicators). The stock shows mixed fundamentals with strong revenue growth projected ($2.6B in 2026) but negative 2025 net income of -$16.94M and thin 0.31% net margin. Recent earnings show two misses against expectations, though Q4 2025 beat estimates. Analyst consensus remains bullish with $60.33 price target despite technical weakness.
SYM presents a growth story with $22.5B backlog and expanding AI/robotics market positioning, but faces execution risks from customer concentration (85% Walmart revenue) and profitability challenges. The stock trades at premium valuations (P/E 1,051.5, EV/EBITDA 74.05) requiring significant future earnings growth to justify. Near-term support at $40-42 levels critical for maintaining current pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
